SCI Pharmtech Inc (4119) — Financial Flexibility Index
SCI Pharmtech Inc (4119) has a Financial Flexibility Index of 0.09x as of March 2026. Free cash flow of NT$144.23 Million (operating CF NT$36.89 Million minus capex NT$107.34 Million) represents 0% of total liabilities (NT$1.54 Billion). Check asset allocation strategy of SCI Pharmtech Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SCI Pharmtech Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for SCI Pharmtech Inc across 23 annual periods. See SCI Pharmtech Inc (4119) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SCI Pharmtech Inc (2002–2025)
Year-by-year free cash flow to debt coverage for SCI Pharmtech Inc. For the full company profile including market capitalisation, see SCI Pharmtech Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | NT$830.32 Million | NT$220.32 Million | NT$1.49 Billion | ▼ -46.9% |
| 2024 | 1.05x | NT$1.81 Billion | NT$860.52 Million | NT$1.72 Billion | ▲ +33.9% |
| 2023 | 0.78x | NT$1.25 Billion | NT$215.77 Million | NT$1.59 Billion | ▼ -28.8% |
| 2022 | 1.10x | NT$1.46 Billion | NT$296.56 Million | NT$1.33 Billion | ▼ -9.4% |
| 2021 | 1.21x | NT$1.06 Billion | NT$280.28 Million | NT$869.26 Million | ▲ +27.4% |
| 2020 | 0.95x | NT$1.19 Billion | NT$971.53 Million | NT$1.25 Billion | ▼ -41.9% |
| 2019 | 1.64x | NT$996.08 Million | NT$791.60 Million | NT$606.84 Million | ▲ +47.9% |
| 2018 | 1.11x | NT$642.63 Million | NT$480.18 Million | NT$578.85 Million | ▼ -5.3% |
| 2017 | 1.17x | NT$429.04 Million | NT$281.65 Million | NT$365.88 Million | ▼ -17.2% |
| 2016 | 1.42x | NT$679.31 Million | NT$502.11 Million | NT$479.43 Million | ▲ +11.8% |
| 2015 | 1.27x | NT$880.75 Million | NT$663.24 Million | NT$695.02 Million | ▲ +73.2% |
| 2014 | 0.73x | NT$727.92 Million | NT$358.77 Million | NT$994.64 Million | ▼ -28.8% |
| 2013 | 1.03x | NT$1.01 Billion | NT$238.57 Million | NT$984.62 Million | ▼ -41.8% |
| 2012 | 1.76x | NT$566.47 Million | NT$385.57 Million | NT$321.12 Million | ▲ +71.1% |
| 2011 | 1.03x | NT$397.26 Million | NT$249.55 Million | NT$385.26 Million | ▼ -5.9% |
| 2010 | 1.10x | NT$409.30 Million | NT$218.96 Million | NT$373.37 Million | ▼ -52.8% |
| 2009 | 2.32x | NT$498.09 Million | NT$316.96 Million | NT$214.32 Million | ▲ +15.3% |
| 2008 | 2.02x | NT$383.42 Million | NT$245.29 Million | NT$190.16 Million | ▲ +6.5% |
| 2007 | 1.89x | NT$334.74 Million | NT$167.53 Million | NT$176.74 Million | ▼ -38.8% |
| 2006 | 3.09x | NT$293.62 Million | NT$131.62 Million | NT$94.94 Million | ▲ +255.8% |
| 2004 | 0.87x | NT$112.16 Million | NT$76.61 Million | NT$129.03 Million | ▼ -70.9% |
| 2003 | 2.98x | NT$307.15 Million | NT$206.86 Million | NT$102.99 Million | ▲ +416.4% |
| 2002 | 0.58x | NT$148.85 Million | NT$107.12 Million | NT$257.76 Million | — |